Search Results
Found 1275 results for ""
ACRCSP Common Questions About FIT Dec 2015
attachment
Alberta Colorectal Cancer Screening Program Common Questions about the Fecal Immunochemical Test (FIT) About Colorectal Cancer and Screening What is colorectal cancer? Colorectal cancer is cancer that starts in the colon or rectum. Part of the digestive system, the colon and rectum are also called the large bowel or large…
ACRCSP Colorectal-Cancer-Screening-CPG-Summary-Chart Nov 2013
attachment
COLORECTAL CANCER SCREENING Summary of the Clinical Practice Guideline | November 2013 TARGET POPULATION Asymptomatic men and women of all ages EXCLUSIONS Men and women with signs or symptoms suggesting colorectal cancer screening (CRC) RISK ASSESSMENT Assess risk for colorectal cancer (CRC) for all men and women to determine…
colowait
attachment
ACRCSP Colonoscopy Prioritization Waittimes Feb 2016
attachment
ACRCSP Screening-Related Colonoscopy Prioritization and Expected Wait Times Priority of Referral Urgent Abnormal FIT Asymptomatic, average risk men and women aged 50 - 74 Moderate Increased risk individuals overdue for screening or surveillance Polyp found on: Sigmoidoscopy CT Colonography Reason for Referral Hereditary cancer syndromes3 Hereditary Nonpolyposis Colorectal…
colocpg
attachment
ACRCSP Clinical Practice Guidelines June 2013
attachment
COLORECTAL CANCER SCREENING Clinical Practice Guideline | November 2013 TARGET POPULATION Asymptomatic men and women of all ages EXCLUSIONS Men and women with signs or symptoms suggesting colorectal cancer screening (CRC) RECOMMENDATIONS RISK ASSESSMENT Assess risk for colorectal cancer (CRC) for all men and women to determine when to…
colocomm
attachment
ACRCSP Brochure Colorectal Cancer Screening Common Questions Aug 2019
attachment
What happens if the test result is abnormal? Your doctor or healthcare provider will arrange for you to do the FIT at home. Once you are finished with the test, you bring it to the lab. The test result is then sent to your healthcare provider. To learn more about…
